Latest Capital Raise News

G11 Resources has completed a strategic acquisition and raised $7.5 million to fund exploration drilling targeting major copper and gold deposits in Tasmania and NSW. The company identified a significant new geophysical anomaly adjacent to the Mt Lyell mine, setting the stage for a busy 2026.

WIN Metals has unveiled a robust scoping study for its Butchers Creek Gold Project, confirming a 9-year mine life and solid economics, while exceptional high-grade drilling at its Radio Gold Project points to near-term development potential.

Metal Bank Limited ended December 2025 with nearly $2 million in cash and has since bolstered its liquidity through a significant asset sale and share placement. These moves position the company for sustained exploration activity amid cautious operating cash flows.

Metal Bank Limited has completed its acquisition of Hastings Technology Metals’ WA gold assets and is advancing multiple projects towards near-term production, supported by a recent $2.42 million capital raise.

Trek Metals has announced a breakthrough high-grade manganese discovery at its Christmas Creek Project in Western Australia, with rock chip assays reaching up to 60.1% manganese. A major drilling campaign is planned for early 2026 to explore the full potential of this promising find.

Aureka Limited reports breakthrough high-grade gold assays at its Irvine and St Arnaud projects, alongside a successful $3.6 million capital raise to accelerate exploration in Victoria’s historic goldfields.

AnteoTech has raised A$3.5 million through a discounted share placement to accelerate commercialisation of its advanced battery and life sciences technologies globally. The capital injection supports strategic partnerships and sales expansion in key markets including the US and India.

HeraMED Limited has completed a $3.2 million placement to fund its global rollout of digital maternity care solutions, backed by new and existing institutional investors.

Australian Dairy Nutritionals Limited (AHF) is raising approximately $3.47 million through a pro-rata entitlement offer to accelerate its growth plans in China and enhance processing efficiency.

Neurizon Therapeutics has successfully raised $5.88 million through a well-supported entitlement offer, reinforcing investor confidence as it prepares to advance its lead drug candidate NUZ-001 in the HEALEY ALS Platform Trial.

Magnetic Resources NL has strengthened its financial position with a significant equity raise, ending December 2025 with a robust cash balance of $35.4 million. Despite ongoing exploration expenses, the company’s funding runway now extends beyond 18 quarters.

Talius Group reported a positive operating cash flow for the December quarter, alongside a 3% rise in subscriptions and a $4 million capital placement. The company also announced a CEO succession and expanded its international footprint with new pilot programs.